Bioventus (BVS) EBT Margin (2020 - 2026)
Bioventus' (BVS) quarterly EBT Margin came in at 3.42% in Q1 2026, up 618.0% YoY from 0.48% in Q1 2025, and down 61.82% on a QoQ basis from 8.96% in Q4 2025.
Bioventus (BVS) EBT Margin (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of EBT Margin data on file, last reported at 3.42% in Q1 2026.
- Quarterly EBT Margin rose 618.0% year-over-year to 3.42% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5.84% (up 1470.0% YoY) and the FY2025 annual result came in at 4.53%, up 1366.0% from the prior year.
- EBT Margin eased to 3.42% in Q1 2026, from 8.96% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 8.96% in Q4 2025 to a low of 101.47% in Q4 2022.
- A 5-year average of 15.55% and a median of 4.23% in 2024 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin sank 9858 bps — and 2023, when it surged 9469 bps.
- Tracing BVS's EBT Margin over 5 years: stood at 25.78% in 2022, then jumped by 76 bps to 6.21% in 2023, then soared by 99 bps to 0.03% in 2024, then soared by 26065 bps to 8.96% in 2025, then plunged by 62 bps to 3.42% in 2026.
- The last three EBT Margin figures came in at 3.42% (Q1 2026), 8.96% (Q4 2025), and 3.37% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 12.10% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 23.74% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 19.48% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 29.86% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 24.27% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 13.09% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 8.91% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 18.32% |
| 10 | Bioventus | 966.46 Mn | 937.00 Mn | 105.67 Mn | 9.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 9.99% |
| Mar 28, 2026 | 3.42% |
| Dec 31, 2025 | 8.96% |
| Sep 27, 2025 | 3.37% |
| Jun 28, 2025 | 6.98% |
| Mar 29, 2025 | -2.76% |
| Dec 31, 2024 | -0.03% |
| Sep 28, 2024 | -3.78% |
| Jun 29, 2024 | -27.48% |
| Mar 30, 2024 | -4.23% |
| Dec 31, 2023 | -6.21% |
| Sep 30, 2023 | -6.78% |
| Jul 1, 2023 | -3.17% |
| Apr 1, 2023 | -84.13% |
| Dec 31, 2022 | -25.78% |
| Oct 1, 2022 | -101.47% |
| Jul 2, 2022 | -4.62% |
| Apr 2, 2022 | -16.66% |
| Dec 31, 2021 | -2.11% |
| Oct 2, 2021 | -2.89% |